Search
for
Sort by
Research 211–240 of 1000+
- Familial aggregation of alopecia areata
- Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis
- Lymphocytes, neuropeptides, and genes involved in alopecia areata
- Transplantation immunology: Solid organ and bone marrow
- Skin manifestations of celiac disease
- Alopecia areata: Pathogenesis and treatment
- Impaired Notch‐MKP‐1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology
- Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata
- Identification of drug-specific public TCR driving severe cutaneous adverse reactions
- Learning from nudity: lessons from the nude phenotype
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- FOXN1: A Master Regulator Gene of Thymic Epithelial Development Program
- Dissecting the microenvironment around biosynthetic scaffolds in murine skin wound healing
- Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- miR‐218‐5p regulates skin and hair follicle development through Wnt/β‐catenin signaling pathway by targeting SFRP2
- Decreased lymphocyte reactivity and auto-immunity in alopecia areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Type 1 interferon signature in the scalp lesions of alopecia areata
- Loss of epidermal Evi/Wls results in a phenotype resembling psoriasiform dermatitis
- Alopecia areata and the gut—the link opens up for novel therapeutic interventions
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
- Histopathology of alopecia areata, acute and chronic: Why is it important to the clinician?
- Alefacept for Severe Alopecia Areata
- Current and Potential Agents for the Treatment of Alopecia Areata>
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Hyperplasia of Hair Follicles and Other Adnexal Structures in Cutaneous Lymphoproliferative Disorders